A novel biomarker for chemotherapy-associated venous thromboembolism
Ovarian cancer patients are at high risk of venous thromboembolism (VTE). More than 80% of women present with a...
Epidemiology
Risk assessment of thromboembolic events in hospitalized cancer patients: the INDICATE study
Background Thromboprophylaxis (TP) with low-molecular-weight heparins (LMWHs) and direct oral anticoagulants (DOACs)...
VTE risk in patients with lung cancer
Lung cancer is associated with a very high risk of developing venous thromboembolism (VTE). In a large...
Long-term cancer survivors: a growing population at risk
Continued rapid advancement in cancer treatment and early cancer detection have resulted in a steady growth of the...
Isolated Distal DVT In Cancer Patients: What Do Recent Studies Suggest?
In a recent issue of the Journal of Thrombosis and Hemostasis, we report that cancer patients with isolated distal deep...
Contemporary breast cancer treatment-associated venous thromboembolism
Breast cancer patients have a three-to four fold increased risk of venous thromboembolism (VTE) when compared to women...
Venous thromboembolism in blood or marrow transplant recipients
Cancer is a well-recognized risk factor for venous thromboembolism (VTE) and several risk prediction models have been...
Risk factors and prevention of venous thromboembolism in ambulatory cancer patients requiring chemotherapy
Epidemiology and risk factors Venous thromboembolism (VTE) is a burdensome and frequent complication in patients with...
Is thrombosis of retinal veins a marker of occult cancer?
Although thrombosis of the retinal veins (either central or branch retinal vein thrombosis) is usually perceived as...
Risk of thromboembolism in cancer patients with Port-a-Cath. Results and implications of the ONCOCIP study
The normal experience of cancer patients who receive an implantable venous access device (Port-a-Cath) for chemotherapy...